Financhill
Back

Apellis Pharmaceuticals, Inc. Vs. Sanara MedTech, Inc. Industry Stock Comparison

Buy
56

APLS
Apellis Pharmaceuticals, Inc.

Last Price:
$25.54
Seasonality Move:
7.92%
Sell
35

SMTI
Sanara MedTech, Inc.

Last Price:
$25.24
Seasonality Move:
42.72%
Buy
56
Apellis Pharmaceuticals, Inc. (APLS) is a Buy

Is Apellis Pharmaceuticals, Inc. a Buy, Sell or Hold?

  • The current Apellis Pharmaceuticals, Inc. [APLS] share price is $25.31. The Score for APLS is 56, which is 12% above its historic median score of 50, and infers lower risk than normal.
  • APLS is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
35
Sanara MedTech, Inc. (SMTI) is a Sell

Is Sanara MedTech, Inc. a Buy, Sell or Hold?

  • The current Sanara MedTech, Inc. [SMTI] share price is $25.20. The Score for SMTI is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • SMTI is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

APLS Stock Price Chart

What is Apellis Pharmaceuticals, Inc.'s stock price today?

  • The Apellis Pharmaceuticals, Inc. share price today is $25.31
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and APLS is experiencing slight buying pressure.

SMTI Stock Price Chart

What is Sanara MedTech, Inc.'s stock price today?

  • The Sanara MedTech, Inc. share price today is $25.20
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and SMTI is experiencing slight selling pressure.

APLS Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0.83 Buy
Relative Strength Index (14 RSI): 66.13 Buy
Chaikin Money Flow: 983973 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.69 - 23.77) Buy
Bollinger Bands (100): (20.97 - 27.01) Buy

SMTI Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.06 Sell
Relative Strength Index (14 RSI): 57.44 Buy
Chaikin Money Flow: -19103 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.57 - 24.15) Buy
Bollinger Bands (100): (23.59 - 33.11) Sell

APLS Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 24.49 Buy
20-day SMA: 22.18 Buy
50-day SMA: 23.14 Buy
200-day SMA: 21.91 Buy
8-day EMA: 24.29 Buy
20-day EMA: 23.08 Buy
50-day EMA: 22.9 Buy
200-day EMA: 24.26 Buy

SMTI Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23.92 Buy
20-day SMA: 21.76 Buy
50-day SMA: 25.72 Sell
200-day SMA: 29.24 Sell
8-day EMA: 24.05 Buy
20-day EMA: 23.33 Buy
50-day EMA: 25.13 Buy
200-day EMA: 28.91 Sell

Apellis Pharmaceuticals, Inc. Earnings Growth & APLS Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.24 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.00 per share, and a decrease next year of $1.42 per share.

Sanara MedTech, Inc. Earnings Growth & SMTI Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Apellis Pharmaceuticals, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Sanara MedTech, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):